General Information of the Compound
Compound ID
CP0496699
Compound Name
4-(Benzylamino)quinazoline deriv. 38
    Show/Hide
Structure
Formula
C16H15N3O2
Molecular Weight
281.315
Canonical SMILES
COc1cc2c(NCc3ccccc3)ncnc2cc1O
    Show/Hide
InChI
InChI=1S/C16H15N3O2/c1-21-15-7-12-13(8-14(15)20)18-10-19-16(12)17-9-11-5-3-2-4-6-11/h2-8,10,20H,9H2,1H3,(H,17,18,19)
    Show/Hide
InChIKey
YKDOURWNBDLSNO-UHFFFAOYSA-N
Physicochemical Property
logP
2.9561
Rotatable Bonds
4
Heavy Atom Count
21
Polar Areas
67.27
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 135402837
SID: 15071662
ChEMBL ID
CHEMBL333851
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00922, Epidermal growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000052 A-431 Homo sapiens (Human)  1
1
IC50 = 588 nM
   TI
   LI
   LO
   TS